Back

Physicians and patients adherence to guidelines is associated with better prognosis in patients with heart failure: insights from the Optimize Heart Failure Care Program

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Strategies to optimize established heart failure therapies Epidemiology, Prognosis, Outcome ESC Premium Access ESC Congress 2018

About the speaker

Photo
Professor Yury Lopatin

Volgograd State Medical University, Volgograd (Russian Federation)

6 More presentations in this session

Presentation thumbnail
Impact of mineralocorticoid receptor antagonists on sudden cardiac death in patients with heart failure and left ventricular systolic dysfunction: a meta-analysis of three randomized controlled trials
Doctor F. Rossello (Palma de Mallorca, ES)
Abstract Slides Video
Presentation thumbnail
Right ventricular dysfunction in patients with reduced and mid-range ejection fraction: an echocardiographic study on the biventricular dysfunction in heart failure patients.
Doctor M. Squillace (Milan, IT)
Abstract
Presentation thumbnail
The impact of serum concentration guided digoxin therapy on mortality: a long-term follow-up, propensity-matched cohort study
Doctor B. Muk (Budapest, HU)
Abstract Slides Video
Presentation thumbnail
Guideline-recommended medication including mineralocorticoid-receptor antagonists is associated with better long-term outcomes in octogenarian patients with acute heart failure.
Doctor T. Abe (Kawagoe, JP)
Abstract Slides Video
Presentation thumbnail
Effectiveness of the pharmacist-involved multidisciplinary management of heart failure to improve readmission and mortality rates: systematic review and meta-analysis of randomized controlled trials
Mr D. Parajuli (Renmark, AU)
Abstract Slides Video

Access the full session

Session thumbnail
Strategies to optimize established heart failure therapies

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources